Browse diseases

… least two cardiometabolic diseases, involving type 2 diabetes, ischaemic heart disease and stroke.Results After a median follow-up of 13.7 years, 4445…

…PNS provides persistent and clinically meaningful analgesia for chronic pain, with benefits sustained up to 24 months. These findings suppor…

…Background The efficacy of spinal cord stimulation (SCS) in chronic pain studies is traditionally assessed by pain scores, which do not …

…ts recognise the biopsychosocial model as important in treating chronic pain. However, the adoption of this model in Dutch private practice …

…n cannot be better accounted for by another condition. CPGs for chronic primary pain, agnostic to condition or body part, may support clinicians tow…

…Background and Aims Chronic pain is increasingly understood as a biopsychosocial condition invol…

…nd expression therapy.Methods Adults (N=42) with mixed-etiology chronic pain and trauma exposure were enrolled. STEPP was delivered remotely…

… a naturalistic clinical sample of people seeking treatment for chronic pain, which may provide preliminary evidence for its validity and ap…

…rdinated working across whole systems.Aim Improve management of chronic pain by reducing chronic and high-dose opioid prescribing and increa…

…he explantation of neuromodulation devices for the treatment of chronic pain from different manufacturers.Methods This retrospective analysi…

…S may be effective for reducing pain intensity in patients with chronic pain up to 24 months postimplantation, although no changes in opioid…

…ree hours of care. Exploratory outcomes included development of PTSD and chronic pain at 90-days. Analyses used descriptive statisti…